Alyssa Danno

Henry Ford Hospital

Papers

1

Total Citations

45

H-Index

1

About

Alyssa Danno is a dedicated urologic oncology researcher whose work centers on improving outcomes for patients with upper tract urothelial carcinoma (UTUC). Her primary research areas include minimally invasive surgical techniques, intravesical recurrence (IVR) after nephroureterectomy, and risk stratification for cancer recurrence. Danno’s most impactful contribution comes from her involvement in the ROBUUST Collaboration, where she co-authored a pivotal 2021 study analyzing risk factors for IVR following robotic nephroureterectomy. This work, which has garnered 45 citations, addressed a critical gap by focusing specifically on minimally invasive cohorts, revealing that prior bladder cancer history and tumor location are key predictors of recurrence. By clarifying these risks, her research helps guide postoperative surveillance and adjuvant therapy decisions. Danno’s work is notable for its collaborative, multi-institutional approach, enhancing the generalizability of her findings. Her contributions are shaping clinical protocols for UTUC management, making her a rising voice in urologic oncology. For students and researchers, Danno exemplifies how targeted, collaborative research can directly impact patient care and surgical decision-making.

Research Focus

Key Achievements

1
H-Index
1
Papers
45
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration)
45 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Henry Ford Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago